Technical clinical information. You will have to register to read it but it is free (thanks Chris)
Immunotherapeutic Approaches Have the Potential to Brighten the Future Not Only for Patients With del(17p13.1), but for All CLL Patients
Review Article... Fabienne McClanahan, MD, John G. Gribben, MD,
cancernetwork.com/leukemia/...
del(17p13.1): A Distinct Clinical Subtype Requiring Novel Treatment Approaches
Review Article... Deborah M. Stephens, DO, John C. Byrd, MD
cancernetwork.com/leukemia/...
Deletion 17p: Emerging Treatment Options
Review Article... Nitin Jain, MD, Susan O’Brien, MD